日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Vericiguat and mortality in heart failure and reduced ejection fraction: the VICTOR trial

维利西呱与射血分数降低的心力衰竭患者的死亡率:VICTOR试验

Butler, Javed; Fioretti, Francesco; McMullan, Ciaran J; Anstrom, Kevin J; Barash, Irina; Bonaca, Marc P; Borentain, Maria; Corda, Stefano; Teixeira, Pedro P; Ezekowitz, Justin A; Gates, Davis; Lam, Carolyn S P; Lewis, Eldrin F; Lindenfeld, JoAnn; Mentz, Robert J; O'Connor, Christopher M; Ponikowski, Piotr; Reddy, Yogesh N V; Rosano, Giuseppe M C; Saldarriaga, Clara; Senni, Michele; Udelson, James; Urbinati, Alessia; Vlajnic, Vanja; Voors, Adriaan A; Xing, Aiwen; Patel, Mahesh J; Zannad, Faiez

Erratum: Development of clinical research networks in rural America: Our experience from the Accelerating COVID-19 Therapeutic Interventions and Vaccines-1 trial - CORRIGENDUM

勘误:美国农村地区临床研究网络的发展:我们从加速 COVID-19 治疗干预和疫苗-1 试验中的经验——更正

Kedar, Eyal; Dandachi, Dima; Bryant, Alexis; Anstrom, Kevin J; Powderly, William

Using Artificial Intelligence to Assess Treatment-Effect Heterogeneity in Pragmatic Cardiovascular Trials: Insights from TRANSFORM-HF

利用人工智能评估实用性心血管试验中治疗效果异质性:来自 TRANSFORM-HF 研究的启示

Tong, Guangyu; Li, Changjun; Li, Fan; Zeng, Yukang; Greene, Stephen J; Anstrom, Kevin J; Testani, Jeffrey; Mentz, Robert J; Velazquez, Eric J

Multivitamins After Myocardial Infarction in Patients With Diabetes: A Randomized Clinical Trial

糖尿病患者心肌梗死后服用多种维生素:一项随机临床试验

Ujueta, Francisco; Lamas, Gervasio A; Anstrom, Kevin J; Navas-Acien, Ana; Boineau, Robin; Rosenberg, Yves; Stylianou, Mario; Jones, Teresa L Z; Joubert, Bonnie R; Yu, Qilu; Wen, Jun; Nemeth, Hayley; Huang, Zhen; Fonseca, Vivian; Nathan, David M; Uwaifo, Gabriel; Arenas, Ivan A; Luo, Lan; Baker, Jeffrey; Visentin, Diana; Paixao, Andre; Schmedtje, John F Jr; Mark, Daniel B

Diuretic dosing and outcomes with torsemide and furosemide following hospitalization for heart failure: The TRANSFORM-HF trial

托拉塞米和呋塞米用于心力衰竭住院患者的利尿剂剂量和疗效:TRANSFORM-HF试验

Nouhravesh, Nina; Greene, Stephen J; Clare, Robert; Wojdyla, Daniel; Anstrom, Kevin J; Velazquez, Eric; Pitt, Bertram; Mentz, Robert J; Psotka, Mitchell A

Vericiguat Global Study in Participants with Chronic Heart Failure: Design of the VICTOR trial

维利西呱治疗慢性心力衰竭患者的全球研究:VICTOR试验设计

Reddy, Yogesh N V; Butler, Javed; Anstrom, Kevin J; Blaustein, Robert O; Bonaca, Marc P; Corda, Stefano; Ezekowitz, Justin A; Lam, Carolyn S P; Lewis, Eldrin F; Lindenfeld, JoAnn; McMullan, Ciaran J; Mentz, Robert J; O'Connor, Christopher; Patel, Mahesh; Ponikowski, Piotr; Rosano, Giuseppe M C; Saldarriaga, Clara I; Senni, Michele; Udelson, James; Voors, Adriaan A; Zannad, Faiez

Quality of Life Outcomes With a Risk-Based Precision Testing Strategy Versus Usual Testing in Stable Patients With Suspected Coronary Disease: Results From the PRECISE Randomized Trial

在疑似冠心病的稳定型患者中,基于风险的精准检测策略与常规检测对生活质量的影响:PRECISE随机试验的结果

Mark, Daniel B; Li, Yanhong; Nanna, Michael G; Kelsey, Michelle D; Daniels, Melanie R; Rogers, Campbell; Patel, Manesh R; Baloch, Khaula N; Chow, Benjamin J W; Anstrom, Kevin J; Vemulapalli, Sreekanth; Weir-McCall, Jonathan R; Stone, Gregg W; Chew, Derek S; Douglas, Pamela S

Economic Outcomes With Precision Diagnostic Testing Versus Usual Testing in Stable Chest Pain: Results From the PRECISE Randomized Trial

精准诊断检测与常规检测在稳定型胸痛中的经济效益比较:PRECISE随机试验结果

Chew, Derek S; Mark, Daniel B; Li, Yanhong; Nanna, Michael G; Kelsey, Michelle D; Daniels, Melanie R; Davidson-Ray, Linda; Baloch, Khaula N; Rogers, Campbell; Patel, Manesh R; Anstrom, Kevin J; Curzen, Nick; Vemulapalli, Sreekanth; Douglas, Pamela S

Projecting the benefit of vericiguat in PARADIGM-HF and DAPA-HF populations: Insights from the VICTORIA trial

预测维利西呱在 PARADIGM-HF 和 DAPA-HF 人群中的获益:来自 VICTORIA 试验的启示

Kittipibul, Veraprapas; Mentz, Robert J; Young, Rebecca; Butler, Javed; Ezekowitz, Justin A; Lam, Carolyn S P; Ponikowski, Piotr; Voors, Adriaan; Corda, Stefano; McMullan, Ciaran; O'Connor, Christopher M; Anstrom, Kevin J; Armstrong, Paul W

SARS-CoV-2 N protein and anti-spike serologies: insights into COVID-19 disease severity and mortality-a secondary analysis of the ACTIV-1 trial

SARS-CoV-2 N 蛋白和抗刺突蛋白血清学:对 COVID-19 疾病严重程度和死亡率的深入了解——ACTIV-1 试验的二次分析

Mena Lora, Alfredo J; Enders, Kimi; Wu, Huimin; Parra-Rodriguez, Luis; Palma, Christopher; Saliba, Katy; Laverdurre, Sylvain; Smith, P Brian; Anstrom, Kevin J; Bozzette, Samuel A; Powderly, William G